Simulation of Membrane and Cell Culture Permeability and Transport. Michael B. Bolger and Viera Lukacova Simulations Plus, Inc.

Similar documents
Predicting a Drug s Membrane Permeability: A Computational Model Validated With in Vitro Permeability Assay Data

Simulation of the Nonlinear PK of Gabapentin and Midazolam in. Adult and Pediatric Populations. Population Approach Group in Europe (PAGE)

THE IMPORTANCE OF AND DIFFERENT APPROACHES TO PERMEABILITY DETERMINATION

Metformin: Mechanistic Absorption Modeling and IVIVC Development

Use of PBPK in simulating drug concentrations in pediatric populations: Case studies of Midazolam and Gabapentin

Chromatography on Immobilized Artificial Membrane

Define the terms biopharmaceutics and bioavailability.

Many drugs have both lipophilic and hydrophilic chemical substituents. Those drugs that are more lipid soluble tend to traverse cell membranes more

Pharmacokinetics Dr. Iman Lec. 3

Drug permeability across biological barriers estimated by the PVPA

Viera Lukacova Director, Simulation Sciences

NANO 243/CENG 207 Course Use Only

The ADME properties of most drugs strongly depends on the ability of the drug to pass through membranes via simple diffusion.

Mechanistic Modeling of in vitro Assays to Improve in vitro/in vivo Extrapolation

Quantitative Evaluation of the Effect of P-Glycoprotein on Oral Drug Absorption

Exploiting BDDCS and the Role of Transporters

WHY... 8/21/2013 LEARNING OUTCOMES PHARMACOKINETICS I. A Absorption. D Distribution DEFINITION ADME AND THERAPEUIC ACTION

The Influence of Physicochemical Properties on ADME

Drug Release from Liposomes: Role of Mechanism Based Models. Bradley D. Anderson University of Kentucky

Altered GI absorption in special populations: An industry perspective

Permeation prediction of M using the parallel artificial membrane permeability assay.

Development of Canagliflozin: Mechanistic Absorption Modeling During Late-Stage Formulation and Process Optimization

Pharmacokinetic Modeling & Simulation in Discovery and non-clinical Development

ADVANTAGES AND LIMITATIONS OF

Biopharmaceutics Classification System: Defining a Permeability Class

HTPK: Conducting PK modeling and

Dr. Nele Plock. Dr. N. Plock, March 11, 2008, American Conference on Pharmacometrics

Biopharmaceutics Drug Disposition Classification System (BDDCS) and Its Application in Drug Discovery and Development

PK-UK Challenges and benefits of using PBPK to evaluate an IVIVC for drugs with nonideal solubility and/or permeability. Bath, November 2014

The use of mass spectrometry in lipidomics. Outlines

Chapter 3b Cells Membrane transport - Student Notes

USING PBPK MODELING TO SIMULATE THE DISPOSITION OF CANAGLIFLOZIN

Problem Set for Fundamentals 9 Oct 2013

CH 7.2 & 7.4 Biology

Lecture 1: Physicochemical Properties of Drugs and Drug Disposition

Modeling of Ac-ve Transport and Metabolism for in vitro Suspended and Sandwich Hepatocyte Assays U-lizing MembranePlus

Chimica Farmaceutica. Pharmacokinetics and related topics

Mechanisms of Drug Action

7/11/17. Cell Function & Chemistry. Molecular and Cellular Biology. 2. Bio-Chemical Foundations & Key Molecules of a Cell

Lecture Series 4 Cellular Membranes. Reading Assignments. Selective and Semi-permeable Barriers

R 3 NH + + H 2 O R 3 N + H 3 O +

Mass Spectrometry based metabolomics

Lecture Series 4 Cellular Membranes

Supporting Information. Interphase Enzyme Kinetics of an Integral Membrane Kinase by. Time-Resolved Solid-state NMR. contributed equally

Biomembranes structure and function. B. Balen

Summary and general discussion

Pharmacokinetics I. Dr. M.Mothilal Assistant professor

EVE 491/591 Toxicology. Toxicant Entry into the Body 2/19/2018. Absorption and Fate of a Toxicant

TRANSIL ASSAY KITS. Frequently Asked Questions (FAQs)

The Plasma Membrane - Gateway to the Cell

Biopharmaceutics. Lec: 4

BIOL 158: BIOLOGICAL CHEMISTRY II

Early BioPharm Risk Assessment in Discovery. Linette Ruston PCF9 17 th September 2010, Barcelona

The use of Saliva instead of Plasma as a Surrogate in Drug Bioavailability and Bioequivalence Studies in Humans

Lipids Analysis. Lipids

Transport of Solutes and Water

Human and mouse T cell regulation mediated by soluble CD52 interaction with Siglec-10. Esther Bandala-Sanchez, Yuxia Zhang, Simone Reinwald,

Lecture Series 5 Cellular Membranes

Chapter 4: Cell Membrane Structure and Function

Chapter 2 Transport Systems

BASIC PHARMACOKINETICS

A. Membrane Composition and Structure. B. Animal Cell Adhesion. C. Passive Processes of Membrane Transport. D. Active Transport

Recent Advances in Palm Tocotrienol Research: Bioavailability and Health Benefits Revisited

Lecture Series 4 Cellular Membranes

Transport across the cell membrane

TRANSPORT ACROSS MEMBRANES

Bell Work The stomach is located between the esophagus and the small intestine. The stomach secretes digestive enzymes and strong acids to aid in the

Elsje Pienaar 1,2, Jansy Sarathy 3, Brendan Prideaux 3, Jillian Dietzold 4, Véronique Dartois 3, Denise E. Kirschner 2 and Jennifer J.

9/11/18. Cell Function & Chemistry. Molecular and Cellular Biology. 2. Bio-Chemical Foundations & Key Molecules of a Cell

Gateway to the Cell 11/1/2012. The cell membrane is flexible and allows a unicellular organism to move FLUID MOSAIC MODEL

Controlling ADME through Chemical Design. Marty Mulvihill Chris Vulpe

Advantages and Limitations of In Vivo Predictive Dissolution (IPD) Systems

Biological Membranes. Lipid Membranes. Bilayer Permeability. Common Features of Biological Membranes. A highly selective permeability barrier

Simulating the lower intestine based on in vivo data

Glycerolipid Analysis. LC/MS/MS Analytical Services

Diffusion across cell membrane

Describe the Fluid Mosaic Model of membrane structure.

Chem 431A-L24-F 07 admin: Last time: We finished Chapt 7, started Chapt 10 FA s and TG s FA=fatty acid, TG=triglycerides or triacylglycerols

CHAPTER 4 - HOW CELLS WORK. 4.2 The Central Dogma (p. 105) see figure 4.1 (p.106) DNA transcription RNA translation proteins

Interactions Between Cells and the Extracellular Environment

Impact of Chromatography on Lipid Profiling of Liver Tissue Extracts

Biology 2201 Unit 1 Matter & Energy for Life

Membrane transport. Pharmacy Dr. Szilvia Barkó

What do you remember about the cell membrane?

DRUG DISTRIBUTION. Distribution Blood Brain Barrier Protein Binding

Cellular Neurophysiology I Membranes and Ion Channels

Diffusion, Osmosis and Active Transport

Membrane Transport. Anatomy 36 Unit 1

7.3 Cell Boundaries. Regents Biology. Originally prepared by Kim B. Foglia. Revised and adapted by Nhan A. Pham

BIOPHARMACEUTICS and CLINICAL PHARMACY

Pharmacokinetic Phase

Chapter 7 Cell Structure and Function. Chapter 7, Section 3 Cell Boundaries and Transport

A primer on pharmacology

A RAPID AND SENSITIVE UPLC/UV/MS METHOD FOR SIMVASTATIN AND LOVA S TAT IN IN SU P P O RT O F C L E A NING VA L I DAT IO N S T U DIES

Topical Preparations

Body Fluid Compartments and Cell Membranes Linda S. Costanzo, Ph.D.

Paper 4. Biomolecules and their interactions Module 22: Aggregates of lipids: micelles, liposomes and their applications OBJECTIVE

Cell Structure and Function Exam Study Guide Part I

Unit 1 Matter & Energy for Life

HPLC Separation Tools for Membrane Protein Purification and Drug Membrane Permeability Prediction

Transcription:

Simulation of Membrane and Cell Culture Permeability and Transport Michael B. Bolger and Viera Lukacova Simulations Plus, Inc. utline Models of microscopic membrane kinetics Calculation of membrane entry and exit kinetics. Simulation of passive permeability Application to efflux transporter Pgp 1

Epithelial Cell Permeability Assay Parallel Artificial Membrane Permeation Assay PAMPA Li, A.P., DDT, 6(7):339-348 Simplest model only the partitioning in and out of the membrane no concentration gradients the concentration equilibrium in each compartment reached instantaneously Donor (D) Membrane (M) Acceptor (A) k i k o k i k o 2

Extended model 1 Addition of diffusion through unstirred water layer (UWL) in donor and acceptor compartments concentration equilibrium in bulk aqueous phases and membrane - instantaneous Donor bulk (D) Donor UWL (UD) Membrane (M) Acceptor UWL (UA) Acceptor bulk (A) k i k o k i k o D w h w D w h w Extended model 2 - model currently in use Addition of ionization of compounds Assume the diffusion through the aqueous phases is the same for neutral and ionized species partitioning into the membrane - only non-ionized species. Donor bulk (D) Donor UWL (UD) Membrane (M) Acceptor UWL (UA) k i c N k o c N k i c N k o c N Acceptor bulk (A) c N x = c Ux 1+ r= 1 j 10 D w h w 1 j b pkas (j r+ 1) ph s= r + i p= 1 10 p a p ph - pkas s= 1 D w h w c U -total concentration of the drug in the membrane vicinity c N -concentration of un-ionized species a and b - acidic and basic pka i and j- number of acidic and basic pkas x - acceptor or donor (ph in acceptor and donor compartments may be different) 3

Membrane Composition Kansy, M. et al., J. Med. Chem. 41(7):1007 (1998) 1-20% phosphatidylcholine (PC) in hexadecane (BAMPA) (Sugano K., et al., Int. J. Pharmaceut. 228:181 (2001) biomimetic lipid composition similar to intestinal brush border membrane. PC (0.8%) Phosphatidylethanolamine (PE, 0.8%) Phosphatidylserine (PS, 0.2%) Phosphatidylinositol (PI, 0.2%) Cholesterol (CH, 1.0%) Collander R. Acta. Chem. Scand., 5:774 (1951) logp PC /water = log(α) + β logp octanol/water with parameters: α=15 and β=0.73 and R 2 0.73 Membrane Kinetics Prediction of rate constants k i and k o for partitioning to and out of the membrane. Using the relationship and parameters (γ =0.48 and δ =0.286) from Kubinyi: k i γp γ = ; ko = δp + 1 δp + 1 Kubinyi, H., J. Pharm. Sci. 67:262 (1978) 4

Passive Permeability Transcellular CH 3 H H + H 3 N CH 3 CH 3 f (Hydrophobicity, H-Bonding, Ionization) Theoretical Lipid Diffusion as a function of log P and HBDs LD = LD 0 +LD max *exp(-abs(hbd-logpo/w)) 5

ptimized Lipid Diffusion Pe calculated using DL modeled by theoretical relationship between DL and logpo/w for HBD=0 and HBD=3 6

Membrane Accumulation for high log P molecules. Dvorsky-Balaz J. Theor. Biol.185:213 (1997) Membrane Accumulation for high log P molecules. Dvorsky-Balaz J. Theor. Biol.185:213 (1997) 7

Talinolol H 3 C H 3 C H N H log D 9.4 = 3.14 (Langguth) H HN N Basic pka = 9.8 (QMPRPlus) Composite Pgp K m = 412 μm (149 μg/ml) Two sites high (72 μm) and low (1570 μm) (Langguth) Solubility = 1.23 mg/ml (ph = 7.4) (Gramatte) Peff rat = 0.5 x 10-4 cm/s (Langguth) Peff QMPR = 1.68 x 10-4 cm/s CH 3 Image J Analysis of Pgp Micropig H. Tang, AAPS Annual meeting poster, 2002 RT-PCR expression of mrna Western blot of Pgp-1 from proximal to distal SI 8

Mouly, S., Paine, M.F. PharmRes-20(10):1595-1598 (2003) Pgp expression in human SI Talinolol Non-linear Dose Dependence Talinolol Dose Dependence de Mey et al. J. Cardio. Pharmacol. 26(6):879 (1995) Plasma Talinolol Conc. (ng/ml) 1200 25 mg Cmax = 35.1 ng/ml 1000 50 mg Cmax = 105.8 ng/ml 800 100 mg Cmax = 226 ng/ml 600 400 mg Cmax = 1032 ng/ml 400 200 0 0.00 5.00 10.00 15.00 20.00 25.00 30.00 Time (h) 9

Regional Window for Absorption ATP-Binding Cassette Protein Msb (1JSQ) from E. Coli Chang, Science 293:1793 (2001) 10

ATP-Binding Cassette Protein Msb (1JSQ) from E. Coli Chang, Science 293:1793 (2001) 25 and 400 mg Talinolol po Data from: de Mey, C., J. Cardiovasc. Pharmacol. 26(6):879 (1995) courtesy of Peter Langguth and Daniel Wagner 25 mg Fa% = 64 400 mg Fa% = 94 11

GastroPlus PK PD - Simulation of Talinolol Effect on Heart Rate Tubic M, 2006 in press. Conclusions Membrane and cellular simulations can improve our understanding of absorption. Membrane concentration is important for calibration of in vitro transporter kinetics. The present state-of-the-art provides useful (not perfect) simulations. 12